Relay Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Cambridge, MA
RLAY chart
What traders are saying about $RLAY
Latest postsRelay Therapeutics, Inc. news
- Understanding Momentum Shifts in (RLAY)
Stock Traders Daily ·
- JonesTrading Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $31
Moomoo ·
- Jones Trading maintains Relay Therapeutics at Buy, raises price target to $31 from $20
TradingView ·
- Relay Therapeutics (RLAY) Could Be 38% Undervalued On Q3 Earnings And Pipeline Progress
Simply Wall St ·
- Relay Therapeutics Inc. Common Stock (RLAY) Stock Price Today: $17.03
Pluang ·
- How Wider Q3 Losses Will Impact Relay Therapeutics Stock Investors
Simply Wall St ·
- Relay Therapeutics, Inc. Stock 12‑Month Price Target Cut to $27.42, Implies 52% Upside
TradingView ·
- Relay Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Relay Therapeutics Q3 loss smaller than estimates; sees breast cancer trial enrollment complete mid-2027
TradingView ·
- Relay Therapeutics 3Q 2026: Revenue $0 Net loss $81.7M, EPS $(0.37) — 10-Q Summary
TradingView ·
- Relay Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- Relay Therapeutics Reports Q3 2026 Results, $848.6 Million in Cash
TradingView ·
Relay Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $15.4M | $10.0M | $25.5M | $1.4M |
| Net income | -$276.5M | -$337.7M | -$342.0M | -$290.5M |
| Diluted EPS | $-1.61 | $-2.36 | $-2.79 | $-2.59 |
| Total assets (year end) | $621.3M | $871.3M | $844.0M | $1.10B |
| Cash and equivalents (year end) | $84.0M | $124.3M | $143.7M | $151.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Relay Therapeutics, Inc.
- Ticker
- RLAY (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1812364
Frequently asked questions
What exchange is Relay Therapeutics, Inc. listed on?
Relay Therapeutics, Inc. trades on the Nasdaq under the ticker symbol RLAY.
What industry is Relay Therapeutics, Inc. in?
Relay Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Relay Therapeutics, Inc. headquartered?
Relay Therapeutics, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Relay Therapeutics, Inc.'s fiscal year end?
Relay Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Relay Therapeutics, Inc. report?
Relay Therapeutics, Inc. reported $15.4M in revenue for calendar year 2025, according to its SEC filings.